MedTrace Logo

Prevalence of Intrauterine Adhesions After Myomectomy

NCT04030273 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2026-08-17

No results posted yet for this study

Summary

This prospective, multicenter, observational study evaluated the prevalence of intrauterine adhesions after laparoscopic or laparotomic myomectomy and investigated clinical and surgical factors associated with their occurrence. Consecutive women who underwent laparoscopic or laparotomic myomectomy were considered eligible and were approached for enrollment. Women who provided informed consent were included in the study. All included women underwent myomectomy and postoperative management according to routine clinical practice. All enrolled women underwent office diagnostic hysteroscopy three months after surgery to assess the presence of intrauterine adhesions. Clinical characteristics, surgical details of the myomectomy, and hysteroscopic findings were prospectively collected in an anonymized database.

Conditions

  • Myoma;Uterus

Interventions

DIAGNOSTIC_TEST

Diagnostic hysteroscopy

Diagnostic hysteroscopy performed three months after myomectomy in an office setting using a vaginoscopic approach, without cervical dilatation, with a 4.3 mm outer sheath hysteroscope (BETTOCCHI Office Hysteroscope size 5; Karl Storz, Tuttlingen, Germany). Normal saline solution was used as the uterine distension medium.

Sponsors & Collaborators

  • University of Miami

    collaborator OTHER

  • Università degli Studi dell'Insubria

    lead OTHER

Principal Investigators

  • Jose Carugno · University of Miami

  • Andrea Tinelli · Vito Fazzi Hospital

  • Antonio Simone Laganà · Università degli Studi dell'Insubria

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-21
Primary Completion
2021-03-29
Completion
2021-03-29

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04030273 on ClinicalTrials.gov